Clinical trial
The Utility of Emsella for Reducing Transient Stress Urinary Incontinence (tSUI) Following Holmium Laser Enucleation of the Prostate (HoLEP)
NCT07580404 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Utility of Emsella for Reducing Transient Stress Urinary Incontinence (tSUI) Following Holmium Laser Enucleation of the Prostate (HoLEP)
- Lead sponsor
- Northwestern University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- June 30, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostatic hyperplasia, enlarged prostate (bph), enlarged prostate with lower urinary tract symptoms